−0.003 BRL
−2.28 B BRL
0.00 BRL
About Denali Therapeutics Inc.
Sector
Industry
CEO
Ryan J. Watts
Website
Headquarters
San Francisco
Founded
2013
ISIN
BRD2NLBDR008
FIGI
BBG014XJ88Y9
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.
DNLI a long-term add over 53.50This is not a commentary on the promising fundamentals or potential of Denali Therapeutics but rather a purely technical analysis. DNLI has been consolidating in a falling wedge pattern coming off a nice run up from August of 2020. Price seems to have found a recent bottom at the all-time 50% fib as
DNLI, Aroon Indicator entered an Uptrend on December 08, 2020.Over the last three days, Tickeron's A.I.dvisor has detected that DNLI's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.